WallStreetZenWallStreetZen

NASDAQ: CNSP
Cns Pharmaceuticals Revenue

OverviewEarningsRevenue
DividendOwnership
Cns Pharmaceuticals revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNSP annual revenue was $0.0, with N/A growth year-over-year.

CNSP revenue history

Current Revenue
$0.0
Current Earnings
-$14.9M
Current Profit Margin
0%

Be the first to know when CNSP announces revenue.

CNSP Revenue History By Year

CNSP Yearly RevenueCNSP RevenueCNSP ChangeCNSP Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Cns Pharmaceuticals Revenue FAQ

What was CNSP's revenue last quarter?

On Invalid Date, Cns Pharmaceuticals (NASDAQ: CNSP) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Cns Pharmaceuticals's revenue was $0.00.

What was Cns Pharmaceuticals's revenue in 2024?

Cns Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Cns Pharmaceuticals make in a day?

Based on Cns Pharmaceuticals annual revenue for the past five years, CNSP makes an average of $0.00 per day.

What was Cns Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Cns Pharmaceuticals's revenue has grown null year over year. Cns Pharmaceuticals's revenue in the past year totaled $0.00.

How much does Cns Pharmaceuticals make in a year?

Cns Pharmaceuticals's revenue by year for the past five years is:
  • Cns Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Cns Pharmaceuticals's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Cns Pharmaceuticals's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Cns Pharmaceuticals's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Cns Pharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.